Morning research

Morning research

StockRadar.ru

Gapping down

In reaction to disappointing earnings/guidance:

  • SPWH -11.8%,WSM -11.7%, (also announces acquisition of Outward, Inc for all cash consideration of $112 mln),CORI -6.5%,DXLG -6.5%,MATW -2.1%,POST -0.9%

M&A news:

  • CHTR -1.1% (WSJ reported Comcast may be interested in Fox acquisition)

Other news:

  • HTBX -14.7% (to offer for sale shares of its common stock in an underwritten public offering; size not disclosed)
  • VBLT -12.2% (to offer 2.5 mln ordinary shares in an underwritten public offering)
  • ICON -6.6% (Iconix Brand receives NASDAQ letter for delayed 10-Q (as expected); Company anticipates filing by January 16 and believes that submission of a plan will not be necessary)
  • MCRN -4.3% (announces secondary offering of 13,090,155 shares of common stock by selling stockholders )

Analyst comments:

  • FITB -0.5% (downgraded to underperform at Macquarie)

Gapping up 

In reaction to strong earnings/guidance:

  • DCIX +30.3%,FL +22.9%,ANF +22.7%,SCVL +21.1%,HIBB +18.9%,SPLK +14.9%,NGVC +9.8%,ROST +8.8%,GPS +7.7%,BKE +7%,SFUN +5.6%,AMAT +3.7%,GLOB +2.1%,LXFT +1.2%,ASND +0.5%

M&A news:

  • FOXA +7.5% (WSJ reported Comcast may be interested in Fox acquisition)
  • TIME +4% (WSJ reporting MDP bid for TIME in $17-20 per share range)

Select Cable related names trading higher in sympathy with the M&A reports:

  • DISCA +4.4%,LGF.A +2%,TWX +0.8%,VIAB +0.6%

Other news:

  • MYOS +5.9% (CEO disclosed purchase of 25000 shares worth approx)
  • IPAS +4% ( enters into common stock purchase agreement with Aspire Capital for the sale of 1,867,692 shares of iPass common stock at $0.54 per share for proceeds of $1,000,000)
  • TSLA +3.7% (introduces new Semi truck & roadster electric models; J.B. Hunt Transport Services (JBHT) placed a reservation to purchase multiple Tesla Semi tractors to be manufactured by Tesla)
  • MXWL +3.4% (Director disclosed purchase of 250K shares valued at approx $1.3 mln)
  • AGIO +2.7% (reports Phase 1 study evaluating single agent ivosidenib)
  • NKE +2.3% (increases quarterly dividend to $0.20/share from $0.18/share)

Analyst comments:

  • SQ +1.3% (upgraded to Outperform from In-line at Evercore ISI)
  • OXY +1.3% (added to Conviction Buy list at Goldman)


Report Page